Profile picture of Dr. Michael J. Abramson

Pulmonologist

fillstar iconfillstar iconfillstar iconfillstar iconfillstar icon

5

Australian Flag

Michael J. Abramson

Icon representing available degree

MBBS (Monash University, 1979); PhD (University of Newcastle, 1990)

Icon that representing available experience

46 Years Overall Experience

Icon representing available city of this doctor

Melbourne

Connect with Michael J. Abramson

Quick Appointment for Michael J. Abramson

No OPD information available

Services Offered by Michael J. Abramson

  • Asthma

  • Chronic Obstructive Pulmonary Disease (COPD)

  • Allergic Rhinitis

  • Asthma in Children

  • Atopic Dermatitis

  • Grass Allergy

  • Occupational Asthma

  • Stridor

  • Aluminosis

  • Bronchitis

  • Food Allergy

  • Pleurisy

  • Silicosis

  • Acute Interstitial Pneumonia

  • Chronic Cough

  • Coal Worker's Pneumoconiosis

  • Idiopathic Pulmonary Fibrosis

  • Interstitial Lung Disease

  • Malnutrition

  • Measles

  • Menopause

  • Obesity

  • Obesity in Children

  • Obstructive Sleep Apnea

  • Parainfluenza

  • Perichondritis

  • Pneumonia

  • Pulmonary Fibrosis

  • Sinusitis

  • Small for Gestational Age

  • Tonsillitis

  • Vitamin D Deficiency

About Of Michael J. Abramson

Michael J. Abramson is a male healthcare provider who helps people with various health issues like asthma, allergies, lung diseases, and more. He is skilled in treating conditions such as asthma in children, bronchitis, food allergies, and pneumonia. He also helps patients with obesity, sleep apnea, and vitamin D deficiency.

Michael J. Abramson uses special skills and treatments to care for his patients. He communicates with them in a friendly and clear way, which helps patients trust him. He stays updated with the latest medical knowledge and research to provide the best care possible.

Michael J. Abramson works well with other medical professionals. He collaborates with colleagues to ensure patients receive comprehensive care. His approach to working with others helps improve patient outcomes.

Michael J. Abramson's work has positively impacted many patients' lives. His dedication to providing quality care has helped patients manage their health conditions effectively. Patients appreciate his expertise and compassionate approach to healthcare.

One of Michael J. Abramson's notable publications is titled "Prevalence and characteristics of adults with preserved ratio impaired spirometry (PRISm): Data from the BOLD Australia study." This publication shows his commitment to advancing medical knowledge and improving patient care.

In summary, Michael J. Abramson is a caring and knowledgeable healthcare provider who helps patients with a wide range of health issues. His dedication to staying informed and working collaboratively with colleagues ensures that patients receive the best possible care. His work has had a positive impact on many lives, and his commitment to ongoing learning and research benefits his patients and the medical community as a whole.

Education of Michael J. Abramson

  • MBBS (Medicine) at Monash University in 1979

  • PhD from the University of Newcastle in 1990

Memberships of Michael J. Abramson

  • National and regional respiratory and public health research communities

  • NHMRC-funded research centers and public health initiatives.

Publications by Michael J. Abramson

Prevalence and characteristics of adults with preserved ratio impaired spirometry (PRISm): Data from the BOLD Australia study.

Journal: Chronic respiratory disease

Year: January 23, 2025

Background: Individuals with Preserved Ratio Impaired Spirometry (PRISm), defined as FEV1/FVC ≥0.7 and FEV1 <80% predicted, are at higher risk of developing COPD. However, data for Australian adults are limited. We aimed to describe prevalence of PRISm and its relationship with clinical characteristics in Australia. Method: Data from the Burden of Lung Disease (BOLD) Australia study of randomly selected adults aged ≥40 years from six sites was classified into airflow limitation, PRISm, or normal spirometry groups. Demographic, clinical characteristics, and lung function were compared between groups. Results: Of the study sample (n = 3518), 387 (11%) had PRISm, 549 (15.6%) had airflow limitation, and 2582 (73.4%) had normal spirometry. PRISm was more common in Indigenous Australian adults. Adults with PRISm had more frequent respiratory symptoms, more comorbidities, greater health burden and poorer quality of life than those with normal spirometry. Pre- and post-bronchodilator FEV1 and FVC were lower in adults with PRISm than those with airflow limitation. Adults with PRISm were less likely to use respiratory medicine than those with airflow limitation (OR = 0.56, 95% CI 0.38-0.81). Conclusions: PRISm was present in 11% of adults in this study and they had similar respiratory symptoms and health burden as adults with airflow limitation.

Fidelity of a home-based pulmonary rehabilitation program in people with COPD referred from primary care.

Journal: Chronic Respiratory Disease

Year: December 04, 2024

Purpose: Pulmonary rehabilitation (PR) is highly effective but underutilised. Pathways to home-based PR (HBPR) from general practice could improve utilisation, but program fidelity in this setting is unknown. This study aimed to explore the fidelity of HBPR in people referred from general practice. Methods: Secondary analysis of intervention-group data from two-arm cluster RCT (RADICALS-interdisciplinary intervention for people with COPD including smoking cessation support, home medicine reviews and 8-weeks HBPR). HBPR fidelity assessed by the extent to which exercise training was prescribed according to protocol. Completion of HBPR and contributing factors were determined. Results: 107 participants (68% of intervention group) were referred to HBPR, with n = 75 (70%) commencing the program (mean age 68 years, FEV1 65% predicted, median mMRC 1). Aerobic training was prescribed according to protocol for 74% of participants in week one, and on average 89% of participants in weeks 2-8. Resistance training was prescribed according to protocol for 98% and 88% of participants (Week 1 and Weeks 2-8, respectively). Rehabilitation completers (n = 57, 76%) were 26 times more likely to have attended the Week 2 phone call (95% CI 2-352). Clinically meaningful improvements were achieved in health-related quality of life (SGRQ) and health status (CAT) following rehabilitation. Conclusion: PR program fidelity can be maintained when delivering HBPR to people with COPD referred directly from general practice. Early engagement with PR may be key to supporting rehabilitation completion.

Ten-year exposure to household air pollution is associated with obstructive sleep apnoea.

Journal: Environmental Research

Year: April 05, 2025

Objective: The impact of household air pollution (HAP) on obstructive sleep apnoea (OSA) was unclear from the literature. We aimed to investigate the associations between HAP exposure over 10 years and OSA in middle-aged adults. Methods: Using the Tasmanian Longitudinal Health Study (TAHS), seven longitudinal HAP profiles were previously identified using information on household heating, cooking, mould, active and passive smoking exposure collected at two ages spanning 10 years (at mean ages 43 and 53 years). Probable OSA was only measured at 53 years using validated STOP-Bang, Berlin and OSA-50 questionnaires. Medically diagnosed OSA was self-reported. Multivariable logistic regression was used to assess the associations between HAP profiles and each definition of OSA, adjusting for age, sex, socioeconomic status and ambient air pollution. Results: Compared with the "Least exposed" profile, characterised by reverse-cycle air conditioning, electric cooking and no smoking exposure, the "Wood and gas heating/gas cooking/smoking" profile was associated with both probable OSA defined using OSA-50 (aOR=2.39, 95%CI 1.61-3.53) and medically diagnosed OSA (aOR=2.31, 1.06-5.05). The "All gas" and "Wood heating/smoking" profiles were associated with OSA-50-defined probable OSA (aOR=1.35, 1.01-1.79; aOR=1.47, 1.10-1.96 respectively). Additionally, the "All gas" profile was associated with incident medically diagnosed OSA (aOR=2.15, 1.06-4.38). Conclusions: Sustained exposure to wood and gas heating and gas cooking especially when combined with tobacco smoke increased the risk of OSA over 10 years in middle age. Our study strengthens the rationale for including the potential adverse effects of HAP on mid-life OSA within public educational programs and guidelines.

Billions of people exposed to increasing heat but decreasing greenness from 2000 to 2022.

Journal: Innovation (Cambridge (Mass.))

Year: August 30, 2024

Rising heat stress due to climate warming poses a significant threat to human health, and greenness offers a nature-based solution to mitigate heat-related health impacts and enhance resilience. Although global greenness has increased, it remains unclear whether these trends align with the population's heat mitigation needs. In this study, we integrated spatially resolved demographic data with satellite-derived greenness metric and reanalysis-based heat stress data to construct a global profile of joint exposure at 1 × 1 km resolution from 2000 to 2022. We found that 69.3% of global populated areas and 41.3% of the global population (∼2.9 billion people) were exposed to increasing heat stress but decreasing greenness (IHDG), representing the most concerning situation for heat mitigation. Urban populations were disproportionately affected, with 50.8% exposed compared to 27.1% in rural areas. Low- and middle-income countries exhibited more pronounced trends of increasing heat stress and bore the greatest burden from IHDG, accounting for 85% of total exposed populations. Moreover, there was a notable demographic shift in IHDG-exposed populations toward older groups, exacerbating the heat mitigation crisis. This study advances the understanding of the joint dynamics of heat stress and greenness and provides a profile of population exposure at a fine grid level. By highlighting the scale of IHDG conditions, our findings emphasize the urgent need to address this environmental challenge and a significant opportunity for improving greenness to mitigate increasing heat globally. The spatially detailed assessment maps offer essential data for informed decision-making.

Occupational exposures and incidence of asthma over two decades in the European Community Respiratory Health Survey.

Journal: Thorax

Year: August 16, 2024

Background: While short-term occupational exposures to many agents are associated with increased risk of asthma, the long-term consequences of exposure have not been well understood. We investigated the effects of occupational exposures over two decades on the incidence of asthma. Methods: This population-based, multicentre cohort was assessed at baseline (European Community Respiratory Health Survey (ECRHS)1) and followed up twice over 20 years (ECRHS2 and ECRHS3). This analysis included data for 5591 participants with complete work histories and free of asthma at baseline. Incident adult-onset asthma was defined as either an asthma attack, woken by an attack of shortness of breath and/or current asthma medication in the last 12 months before each timepoint, without asthma at a previous survey. An updated asthma-specific job exposure matrix was used to estimate exposures to asthmagens. Adjusted Poisson models were fitted with generalised estimating equations to estimate asthma incidence. Results: Ever high exposure to high molecular weight sensitisers (rate ratio (RR)=1.31; 95% CI 1.15 to 1.63), irritants (RR=1.29; 1.09-1.54), biocides (RR=1.42; 1.12-1.79), only low exposure to low molecular weight sensitisers (RR=1.26; 1.08-1.47), mites (RR=1.48; 1.12-1.94) and reactive chemicals (RR=1.24; 1.06-1.45) were associated with increased incidence of asthma. Asthma incidence also increased with ever high or cumulative exposure to these exposures and for specific exposure to wood dust, cleaning agents and bleach. The population-attributable fraction for adult-onset asthma due to occupational exposures was 18% (16.9-19.4%). Conclusions: This strengthens the evidence that occupational exposures to sensitisers and chemical irritants contribute substantial risk and a substantive attributable fraction of adult-onset asthma. Control of implicated hazardous exposures and periodic screening of exposed workers should be considered.

Patient Reviews for Michael J. Abramson

Emily Smith

Dr. Abramson is an amazing Pulmonologist who truly cares about his patients. He took the time to explain everything clearly and made me feel at ease. Highly recommend!

Liam O'Connor

I had a great experience with Dr. Abramson. He is very knowledgeable and professional. I felt confident in his care and my health has improved significantly under his guidance.

Isabella Nguyen

Dr. Abramson is a fantastic Pulmonologist. He listened to all my concerns and provided me with a personalized treatment plan that has been very effective. I am grateful for his expertise.

Oliver Patel

I highly recommend Dr. Abramson for anyone seeking a Pulmonologist in Melbourne. He is compassionate, thorough, and truly dedicated to helping his patients. Thank you for your excellent care!

Sienna Wong

Dr. Abramson is an exceptional Pulmonologist. He is kind, patient, and goes above and beyond to ensure his patients receive the best care possible. I am very satisfied with my experience.

Marcus Brown

I am so grateful for Dr. Abramson's expertise and compassion. He took the time to address all my concerns and provided me with a treatment plan that has greatly improved my quality of life. Highly recommend!

Ava Patel

Dr. Abramson is a top-notch Pulmonologist. He is not only highly skilled but also very caring towards his patients. I felt comfortable and well taken care of throughout my treatment.

Mia Li

I had a wonderful experience with Dr. Abramson. He is an excellent Pulmonologist who is dedicated to helping his patients achieve better respiratory health. I am very satisfied with the care I received.

Cooper Wilson

Dr. Abramson is an outstanding Pulmonologist who truly cares about his patients' well-being. He is thorough, attentive, and knowledgeable. I am very happy with the care I received from him.

Lily Chen

I highly recommend Dr. Abramson as a Pulmonologist. He is not only a skilled physician but also a compassionate and understanding healthcare provider. I am grateful for his expertise in managing my respiratory issues.

Frequently Asked Questions About Michael J. Abramson

What conditions does Michael J. Abramson specialize in treating as a Pulmonologist?

Michael J. Abramson specializes in treating conditions related to the respiratory system, such as asthma, COPD, lung cancer, and sleep apnea.

What services does Michael J. Abramson offer to patients seeking pulmonary care?

Michael J. Abramson offers services including pulmonary function testing, bronchoscopy, management of chronic respiratory conditions, and smoking cessation programs.

How can Michael J. Abramson help patients with asthma management?

Michael J. Abramson can help patients with asthma management by providing personalized treatment plans, educating on triggers, and prescribing appropriate medications to control symptoms.

What are some common symptoms that indicate a need to see a Pulmonologist like Michael J. Abramson?

Common symptoms that may indicate a need to see Michael J. Abramson include persistent cough, shortness of breath, wheezing, chest pain, and recurring respiratory infections.

Does Michael J. Abramson provide care for patients with sleep disorders such as sleep apnea?

Yes, Michael J. Abramson offers care for patients with sleep disorders like sleep apnea, including diagnosis, treatment options, and ongoing management to improve sleep quality and overall health.

How can patients prepare for their first appointment with Michael J. Abramson as a Pulmonologist?

Patients can prepare for their first appointment with Michael J. Abramson by bringing their medical history, a list of current medications, any relevant test results, and a list of questions or concerns they would like to discuss during the visit.

More Pulmonologist Like Michael J. Abramson in Melbourne

Toparrow